Pure Global
NCT06347432

Em-power: Maximizing Functional Independence for Children With Severe Cerebral Palsy

Grand Valley State University·ClinicalTrials.gov·otherNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Cerebral Palsy
Drug/Device/Intervention
Power wheelchair skills training using the IndieTrainer system
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
Grand Valley State University
Location
Grand Rapids, United States of America
Timeline & enrollment
Phase
N/A
Start date
Jul 01, 2024
End date
Mar 01, 2027
Enrollment
16 participants
Primary outcome

Change in understanding how to use a power wheelchair,Change in power wheelchair skill performance

Summary

For children with severe cerebral palsy, a powered wheelchair (PWC) may provide their only
 option for functional mobility and independence. PWC use is often restricted to a small
 percentage of children who can quickly demonstrate proficient PWC skills within a single
 30-minute PWC trial. This 2-arm, parallel group, single blinded, pre-test-post-test
 randomized controlled trial will test our hypothesis that an 8-week PWC skills training
 intervention will produce greater improvements in children's PWC skills capacity immediately
 after the intervention and at an 8-week follow-up assessment.

ICD-10 classifications
Cerebral palsyOther cerebral palsyCerebral palsy, unspecifiedDyskinetic cerebral palsyAtaxic cerebral palsy
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06347432
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06347432 through Pure Global AI's free database. This phase not specified trial is sponsored by Grand Valley State University and is currently Not yet recruiting. The study focuses on Cerebral Palsy. Target enrollment is 16 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.